Octave Specialty Group (OSG) Conference presentation summary
Event summary combining transcript, slides, and related documents.
Conference presentation summary
14 Nov, 2026Business model and strategy
Dual-engine platform combines specialty insurance distribution acquisitions with de novo MGA launches; target 2–4 new ventures annually.
Partnership model aligns founders through retained ownership and profit participation, while providing technology, data infrastructure and integration support.
Organic growth priorities include new products and geographies, distribution expansion, cross-selling, carrier partnerships, and scalable data and technology.
De novo MGAs are generally structured to reach profitability within 18–24 months; recent 2024–2025 launches are expected to scale between 2026 and 2028.
Growth and portfolio
Insurance Distribution revenue rose from $55M in FY2023 to $101M in FY2025; organic revenue growth was 18% in 2024 and 55% in 2025.
1H2026 Insurance Distribution revenue grew 85% to $137M, with 43% organic growth; segment adjusted EBITDA to shareholders was $35M versus $9.6M, and margin was 25.7% versus 13.0%.
Gross premiums placed reached $952M in 2025 and $741M in 1H2026 for Insurance Distribution; total revenue was $251M in 2025.
The pro forma MGA portfolio is diversified across Specialty P&C (74%) and Specialty A&H (26%); distribution spans 13 U.S.-based and 9 London/Bermuda-based MGAs.
2028 adjusted EBITDA aspiration exceeds $80M, implying a stated CAGR of more than 40% from 2024A.
Capacity and underwriting
Available third-party capacity exceeded $2.0B in 1H2026; the majority is described as long-term and scalable.
Everspan reported a 97.1% adjusted combined ratio and 58.6% adjusted loss ratio for 1H2026; adjusted EBITDA to shareholders was $3.4M versus $2.3M.
Everspan holds an AM Best Financial Strength Rating of A- (Excellent) and targets mid-teens ROE at scale with a fee-focused strategy and managed risk exposure.
Consolidated 1H2026 revenue was $187M, up 59% YoY; adjusted EBITDA to shareholders was $24M versus a $6M loss in 1H2025.
Latest events from Octave Specialty Group
- 9M26 revenue rose 67% YoY as a 22-MGA platform targets $80M+ adjusted EBITDA by 2028.OSG
Conference presentation - Distribution growth and Everspan improvement lifted Q3 revenue and adjusted EBITDA amid P&C softening.OSG
Q3 2026 - Executing rapid global MGA growth with strong financials and a scalable, partnership-driven model.OSG
Investor presentation - Revenue up 51% and net loss narrowed, with strong Insurance Distribution and AI platform launch.OSG
Q2 2026 - Director elections, strategic transformation, and AI-driven growth initiatives were key highlights.OSG
AGM 2026 - Transformation completed, compensation aligned, and Board urges support for all proxy proposals.OSG
Proxy filing - Insurance Distribution revenue up 92%, total revenue up 66%, and adjusted EBITDA surged.OSG
Q1 2026 - Shareholders to vote on board, compensation, auditor, and new incentive plan after major transformation.OSG
Proxy filing - Revenue and premium up sharply, but net loss widened; Legacy/AAC sale pending approval.OSG
Q1 2025